Cardiovascular radiosurgery developer CyberHeart said today it inked its 1st development deal to install its CyberHeart system in Tokyo’s National Cancer Center, making it the 1st non-invasive cardiac radiosurgery treatment in Asia.
The CyberHeart system is a non-invasive robotic assisted ablation treatment that uses image-guided tracking of intra-cardiac and other ablation targets for personalized treatments based on a patient’s anatomy, the Mountain View, Calif.-based company said.
“We are excited to offer our patients the most advanced, painless and non-invasive treatment for cardiovascular conditions, and thrilled to be the first center in Asia to offer the use of this breakthrough technology. The CyberHeart system allows patients to undergo ablation for cardiac arrhythmias and other vascular conditions as an outpatient. The personalized nature of the ablation allows the treatment to be tailored to the patient’s individual anatomy,” Dr. Jun Itami of the National Cancer Center said in a press release.
The National Cancer Center in Tokyo expects to begin treating patients shortly, according to CyberHeart.
“A non-invasive treatment approach to cardiac arrhythmias should significantly benefit patients with and without malignancy, and clearly enhance their quality of life,” Dr. Masaaki Shoji of the National Cancer Center said in prepared remarks.
“The installation at NCC is the beginning of international activity for CyberHeart, as this therapy is embraced by physicians in the treatment of cardiac conditions. We are delighted to work with this world-class institution to broaden the scope of therapy and bring it to additional patients,” CEO Dr. Patrick Maguire said in a prepared statement.
